[Federal Register Volume 86, Number 123 (Wednesday, June 30, 2021)]
[Notices]
[Pages 34773-34774]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-13937]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Agency Information Collection Activities: Submission for OMB 
Review; Comment Request

    Periodically, the Substance Abuse and Mental Health Services 
Administration (SAMHSA) will publish a summary of information 
collection requests under OMB review, in compliance with the Paperwork 
Reduction Act (44 U.S.C. Chapter 35). To request a copy of these 
documents, call the SAMHSA Reports Clearance Officer at (240) 276-0361.

Project: 2022 National Survey on Drug Use and Health (OMB No. 0930-
0110)

    SAMHSA is requesting from the Office of Management and Budget (OMB) 
approval to administer the National Survey on Drug Use and Health 
(NSDUH), a survey of the U.S. civilian, non-institutionalized 
population aged 12 years old or older. NSDUH data are used to determine 
the prevalence of use of tobacco products, alcohol, illicit substances, 
and illicit use of prescription drugs. The results are used by SAMHSA, 
the Office of National Drug Control Policy (ONDCP), federal government 
agencies, and other organizations and researchers to establish policy, 
direct program activities, and better allocate resources.
    As certain parts of the United States reduce COVID-19 restrictions, 
NSDUH in-person data collection will proceed where possible. However, 
to ensure sufficient data are collected to produce nationally 
representative estimates for the 2022 survey, NSDUH will continue to 
employ a mix of in-person and web-based modes of administration to 
allow those respondents living in areas with COVID-19 restrictions the 
opportunity to participate. If the COVID-19 pandemic subsides to such 
levels to allow in-person data collection to resume nationwide, SAMHSA 
may reassess that multimode data collection model as part of the 2022 
NSDUH.
    In those areas where in-person data collection is permitted, NSDUH 
protocols, processes, and materials will continue to reflect the need 
to ensure the safety of respondents and field interviewers with respect 
to COVID-19--after initial implementation of such measures beginning in 
October 2020--which include equipping field interviewers with masks, 
gloves, disinfecting wipes, and hand sanitizer for use during data 
collection and providing a COVID-19 risk information form to all 
respondents.
    Unlike previous NSDUHs, a hybrid address-based sampling (ABS) 
design will be implemented for the 2022 NSDUH. ABS refers to the 
sampling of residential addresses from a list based on the U.S. Postal 
Service's Computerized Delivery Sequence file. In areas with high 
expected ABS coverage, the ABS frame will be used. In all other areas, 
traditional field enumeration will be used to construct the dwelling 
unit frames.
    In addition, the NSDUH questionnaire must be updated periodically 
to reflect changing substance use and mental health issues and to 
continue producing current data. For the 2022 NSDUH, the following 
questionnaire updates are planned: (1) Replacing the tobacco module 
with a redesigned nicotine module that includes questions about vaping, 
removes low priority items to reduce respondent burden and eliminates 
outdated terminology; (2) revising the marijuana module to include 
questions about the use of CBD, update questions on the mode of 
administration and eliminate outdated terminology and includes changes 
to the market information for marijuana questions; (3) redesigning the 
adult and youth mental health services utilization modules into one 
Mental Health Service Utilization model to remove questions with 
outdated terminology and include questions about newer treatments with 
recent increases in popularity; and (4) replacing the drug treatment 
module with a redesigned alcohol and drug treatment module that 
includes questions about newer treatments and those that have increased 
in popularity, as well as eliminating outdated terminology and reducing 
respondent burden.
    As with all NSDUH/NHSDA \1\ surveys conducted since 1999, the 
sample size of the NSDUH main study for 2022 will be sufficient to 
permit prevalence estimates for each of the fifty states and the 
District of Columbia. The total annual burden estimate for the NSDUH 
main study is shown below in Table 1.
---------------------------------------------------------------------------

    \1\ Prior to 2002, the NSDUH was referred to as the National 
Household Survey on Drug Abuse (NHSDA).

[[Page 34774]]



                               Table 1--Annualized Estimated Burden for 2022 NSDUH
----------------------------------------------------------------------------------------------------------------
                                     Number of     Responses per   Total number      Hours per     Total burden
           Instrument               respondents     respondent     of responses      response          hours
----------------------------------------------------------------------------------------------------------------
Household Screening.............         168,674               1         168,674           0.083          14,000
Interview.......................          67,507               1          67,507           1.000          67,507
Screening Verification..........           5,060               1           5,060           0.067             339
Interview Verification..........          10,126               1          10,126           0.067             678
                                 -------------------------------------------------------------------------------
    Total.......................         168,674  ..............         251,367  ..............          82,524
----------------------------------------------------------------------------------------------------------------

    Written comments and recommendations for the proposed information 
collection should be sent within 30 days of publication of this notice 
to www.reginfo.gov/public/do/PRAMain. Find this particular information 
collection by selecting ``Currently under 30-day Review--Open for 
Public Comments'' or by using the search function.

Carlos Graham,
Social Science Analyst.
[FR Doc. 2021-13937 Filed 6-29-21; 8:45 am]
BILLING CODE 4162-20-P